FICEBO’s Professor Teppo Järvinen contributes to a global osteoarthritis policy roadmap published in The Lancet! Bringing together experts from 18 countries, the paper calls for stronger recognition of osteoarthritis as a public health priority, better access to evidence-based care, and greater focus on prevention. Read the full paper : thelancet.com/journals/lance… #FICEBO #Osteoarthritis #TheLancet #Research

New faces and new projects! A fresh group of students recently joined Ficebo, bringing new ideas and perspectives to the team. Together, they began working on an AI-based project exploring new ways to collect valuable data from patients. In this video, Aneesh, Adil, and Noa introduce themselves, share their roles, and give a glimpse into the project they’re working on. Stay tuned to see where their ideas take them! Read more about the project here: ficebo.com/post/how-can-we-a…

What do patients really want to know about recovery? At FICEBO, we’re exploring how AI-assisted conversations could help capture the details that matter to patients: symptoms, function, and the activities that are important in everyday life. Read more about the idea, our collaboration with Aalto University students, and the next steps: ficebo.com/post/how-can-we-a… Photo source: Aalto University #FICEBO #PatientCenteredCare #HealthcareAI #ArtificialIntelligence #MedicalResearch

FINCATS is expanding to Tampere University Hospital. The site initiation monitoring visit was successfully completed, and the Tampere team is now getting ready to start patient recruitment in October. A great step forward for the world’s first sham-surgery-controlled trial on carpal tunnel release surgery. Read more about the monitoring visit and the study on our website: ficebo.com/post/fincats-is-e…

Meet Leo, research intern at FICEBO! This summer, upper secondary school student Leo worked on developing an online course on evidence-based medicine. In this video, he shares his project and his experience as part of our research group. Thank you, Leo, for your curiosity and enthusiasm! 🌱 #FICEBO #EvidenceBasedMedicine #ResearchInternship

We’re very happy to celebrate this milestone with Thomas and congratulate him on earning his PhD! A longer story from the dissertation day will follow soon.

FICEBO’s Thomas Ibounig co-authored a new JAMA Internal Medicine review with researchers Romi Haas and Rachelle Buchbinder from Monash University. The article highlights why common shoulder imaging findings don’t necessarily explain pain and why routine imaging is often not needed. Read more about the study and Thomas’s upcoming dissertation on our website: ficebo.com/post/new-review-r… #JAMAInternalMedicine #ShoulderPain #MedicalResearch #EvidenceBasedMedicine #FICEBO

The HARD trial is the first randomized controlled trial to compare first MTP joint fusion with watchful waiting for symptomatic hallux rigidus. In this short video, principal investigator Mikko Miettinen summarizes the key points and findings. FICEBO core members Lasse Rämö and Tuomas Lähdeoja were also involved in the trial. Read more about the HARD trial on our website: ficebo.com/post/fuse-it-or-l… Read the full publication here: acpjournals.org/doi/10.7326/… #HalluxRigidus #Orthopaedics #EvidenceBasedMedicine

New publication! JAMA Internal Medicine review on the diagnosis and management of shoulder pain. Great work Romi Haas, Thomas Ibounig(@IbounigT) and Rachelle Buchbinder(@RachelleBuchbin)! jamanetwork.com/journals/jam…

Thomas Ibounig, LL, will defend his doctoral dissertation “From Images to Insights in the Management of Shoulder Complaints - Prevalence of Shoulder Imaging Abnormalities and their Association with Symptoms in the General Population" in the Faculty of Medicine, University of Helsinki, on 28 August 2026 at 12:00. 📍 Siltasairaala, Töölö-luentosali
Haartmaninkatu 4, Helsinki Opponent: Prof. Karim Khan, University of British Columbia 
Custos: Prof. Teppo Järvinen The full dissertation will be available in Helda from 18 August 2026. More information on the event: tapahtumat.helsinki.fi/en-FI…

The 12-month results of the HARD trial have now been published in Annals of Internal Medicine. The HARD trial is the first randomized controlled trial to compare surgery with watchful waiting in patients with symptomatic hallux rigidus, addressing a decades-old question in the treatment of the painful big toe. Led by principal investigator Mikko Miettinen, the trial compared first metatarsophalangeal joint arthrodesis with watchful waiting. FICEBO core members Lasse Rämö, senior author of the publication, and Tuomas Lähdeoja, co-author, also had the opportunity to contribute to the trial. On our website, you can read more about the trial, hear comments from the research team, and explore the key findings from the newly published results. Read the full news article here: ficebo.com/post/fuse-it-or-l…

Meet Dr. Roope Kalske, Orthopaedic surgeon and PhD student. Roope is balancing life as a spinal surgeon, researcher, husband and father, while going towards an important milestone of his academic career; defending his PhD. Read the full interview on our website: ficebo.com/post/roope-kalske…

Dr. Tuomas Lähdeoja, shoulder and elbow surgeon at FICEBO, contributed to the BMJ Rapid Recommendation on subacromial decompression surgery. Watch this video for a quick introduction of the process. #EvidenceBasedMedicine #Orthopaedics #ShoulderSurgery #MedicalResearch #BMJ

Earlier this spring, the FINCATS team reached an important milestone: the first monitoring for the RCT, site initiation visit (SIV) was completed. After that, the recruitment for the study was permitted to start. For more information, you can read the full news update on our website: ficebo.com/post/fincats-moni… #FINCATS #ClinicalTrials #MedicalResearch #StudyRecruitment #MilestoneReached

The Finnish Carpal Tunnel Study: a new clinical trial examining the effectiveness of carpal tunnel release surgery. FINCATS Team(People in the post, listed from top left to bottom right): Head: Teppo Järvinen; PI’s, Hand surgeons: Susanna Stjenberg-Salmela, Teemu Karjalainen and Jarkko Jokihaara; Clinical research coordinator: Leena Caravitis; Research coordinators: Saara Raatikainen and Kati Jaatinen. You can find more information via this link: ficebo.com/post/introducing-… #CarpalTunnelStudy #ClinicalResearch #Ficebo

The ARC Trial is a multicentre, randomised, placebo-surgery controlled clinical trial investigating the effectiveness of rotator cuff repair in people with chronic shoulder pain thought to be caused by degenerative full-thickness rotator cuff tears. In February 2026, the FICEBO research group joined the study at HUS Helsinki University Hospital, becoming the first and currently the only research centre outside Australia participating in the trial. Members of ARC FICEBO team (from left): PI Tuomas Lähdeoja, Saara Raatikainen, Leena Caravitis, Pirjo Toivonen and Thomas Ibounig. Missing from the picture: radiologist Riikka Korpi and researchers Mikko Salmela, Robert Björkenheim and Eerik Hällfors.

Read more from on our website: ficebo.com/post/arc-trial-ex… #ARCTrial #FICEBO #HUS #HelsinkiUniversityHospital